Christopher Moehle
Jessica Gibson



“Robotics”, “Artificial Intelligence”, and “Machine Learning” have become an almost impossibly broad amalgam of terminologies that span across industries to include everything from the cotton gin to self-driving cars, and touch a broad range of biotechnology and med tech applications.  We address the spread of these transformative technologies across every interpretation of the analogy, including the spectrum ranging from practical, highly economic products to inventive science fiction with speculative business cases.  In this two-part article, we first briefly overview the high-level commonalities between historically successful products and the economic factors driving adoption of these intelligent technologies in our current economy.  In doing so, we focus heavily on “Augmentation” as a central theme of the best products historically, now, and in the near future.  In the second part of the article, we further illustrate how “Augmented Intelligence” can be applied to biotech. This is done through a mini-case study, or a detailed practicum, on Ariel Precision Medicine, to illustrate how “Augmented Intelligence” can be applied to precision medicine currently.